Methyl 2-Oxoindoline-6-Carboxylate CAS 14192-26-8 Kuchena >99.0% (HPLC) Nintedanib Esylate Intermediate Factory

Tsanangudzo Pfupi:

Kemikari Zita: Methyl 2-Oxoindoline-6-Carboxylate

CAS: 14192-26-8

Kuchena:> 99.0% (HPLC)

Chitarisiko: Yero Yero kusvika kuBrown Powder

Yepakati yeNintedanib Esylate (CAS: 656247-18-6) mukurapa kweasiri diki cell cancer yemapapu & idiopathic pulmonary fibrosis (IPF)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Shanghai Ruifu Chemical Co., Ltd. ndiyo inotungamira mugadziri uye mutengesi weMethyl 2-Oxoindoline-6-Carboxylate (CAS: 14192-26-8) ine mhando yepamusoro, kugadzirwa kwekutengesa.

Chemical Properties:

Chemical Name	Methyl 2-Oxoindoline-6-Carboxylate
Mashoko anoreva zvakafanana	2-Oxoindoline-6-Carboxylic Acid Methyl Ester;Methyl Oxindole-6-Carboxylate
Nhamba yeCAS	14192-26-8
Nhamba yeCAT	RF-PI1524
Stock Status	MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula	C10H9NO3
Molecular Weight	191.19
Melting Point	184.0 ~ 190.0℃
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	Yero Yero kusvika kuBrown Powder
1 H NMR Spectrum	Zvinoenderana Nechimiro
Kuchena / Analysis Method	>99.0% (HPLC)
Kurasika paKuomesa	<1.00%
Zvose Zvisina Kuchena	<1.00%
Test Standard	Enterprise Standard
Usage	Pakati peNintedanib Esylate (CAS: 656247-18-6)

Methyl 2-Oxoindoline-6-Carboxylate (CAS: 14192-26-8) Synthetic Route

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro.

Zvakanakira:

FAQ:

Application:

Methyl 2-Oxoindoline-6-Carboxylate (CAS: 14192-26-8) iri pakati inoshandiswa kugadzirira Nintedanib Esylate (CAS: 656247-18-6).Nintedanib Esylate ine simba, yemuromo katatu angiokinase inhibitor yakagadzirwa naBoehringer Ingelheim iyo inotarisa proangiogenic uye pro-fibrotic nzira dzakapindirana nevascular endothelial growth factor receptor, fibroblast growth factor receptor uye plateletderederved growth factor receptor mhuri, pamwe neSrc neFlt-3. kinases.Nintedanib Esylate yakatenderwa kurapwa kweidiopathic pulmonary fibrosis (IPF), mamiriro ekuti mapapu anowedzera mavanga nekufamba kwenguva, neUS FDA muna Gumiguru 2014 uye neEMA muna Ndira 2015. FDA yakapa nintedanib esylate nekukurumidza-track. , kuongororwa kwekutanga, chigadzirwa chenherera, uye mazita ekubudirira.Yakatenderwa zvakare neEMA muna Mbudzi 2014 kurapwa kwegomarara remapapu risiri diki musanganiswa nedocetaxel mushure mekutanga kemotherapy.